NRx Pharmaceuticals Ownership 2024 | Who Owns NRx Pharmaceuticals Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

0.03%

Insider Ownership

26.55%

Retail Ownership

73.42%

Institutional Holders

5.00

NRx Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	2.25%	-	1,478,153	34,990	2.42%	974,250,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.58%	-	378,667	-	-	249,579,000	Mar 31, 2023
BLACKROCK INC.	0.57%	-	375,247	2,718	0.73%	247,325,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.35%	0.00%	230,700	52,000	29.10%	152,054,000	Mar 31, 2023
STATE STREET CORP	0.17%	-	114,240	-	-	75,296,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.13%	-	88,300	-76,900	-46.55%	58,199,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.12%	-	80,623	52,895	190.76%	53,139,000	Mar 31, 2023
NORTHERN TRUST CORP	0.11%	-	71,241	12,643	21.58%	46,955,000	Mar 31, 2023
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC	0.10%	0.00%	63,290	-	-	41,714,000	Mar 31, 2023
HBK SORCE ADVISORY LLC	0.09%	0.00%	58,460	-	-	58,000	Mar 31, 2023
MORGAN STANLEY	0.07%	-	47,326	-3,012	-5.98%	31,193,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.07%	0.00%	46,210	46,210	100.00%	30,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.07%	-	43,732	-	-	28,824,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.05%	-	30,000	-5,809	-16.22%	19,770,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.04%	0.00%	29,400	-75,300	-71.92%	19,378,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.04%	-	29,400	6,900	30.67%	19,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	27,225	-	-	17,933,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.04%	-	25,300	7,700	43.75%	17,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.03%	0.00%	21,326	-25,178	-54.14%	14,056,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	18,611	18,221	4672.05%	12,265,000	Mar 31, 2023

NRx Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 2.25% of the company's total share outstanding, currently valued at $974.25M. The top 10 institutional shareholders own together 4.47% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC	0.10%	0.00%	63,290	-	-	41,714,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.35%	0.00%	230,700	52,000	29.10%	152,054,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.07%	0.00%	46,210	46,210	100.00%	30,000	Mar 31, 2023
UNITED ASSET STRATEGIES, INC.	0.03%	0.00%	18,300	-	-	12,062,000	Mar 31, 2023
HBK SORCE ADVISORY LLC	0.09%	0.00%	58,460	-	-	58,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	14,842	8,740	143.23%	10,000	Mar 31, 2023
CUTLER GROUP LLC / CA	0.00%	0.00%	3,220	-	-	2,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.02%	0.00%	11,141	-4,686	-29.61%	7,343,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.04%	0.00%	29,400	-75,300	-71.92%	19,378,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.03%	0.00%	21,326	-25,178	-54.14%	14,056,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	27,225	-	-	17,933,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.58%	-	378,667	-	-	249,579,000	Mar 31, 2023
VANGUARD GROUP INC	2.25%	-	1,478,153	34,990	2.42%	974,250,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.04%	-	25,300	7,700	43.75%	17,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.01%	-	8,100	-400	-4.71%	5,339,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.00%	-	2,125	1,300	157.58%	1,401,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.04%	-	29,400	6,900	30.67%	19,000	Mar 31, 2023
LARSON FINANCIAL GROUP LLC	0.00%	-	218	-	-	144,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.13%	-	88,300	-76,900	-46.55%	58,199,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.12%	-	80,623	52,895	190.76%	53,139,000	Mar 31, 2023

The largest NRx Pharmaceuticals shareholder by % of total assets is TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC. The company owns 63.29K shares of NRx Pharmaceuticals (NRXP), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.12%	-	80,623	52,895	190.76%	53,139,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.35%	0.00%	230,700	52,000	29.10%	152,054,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.07%	0.00%	46,210	46,210	100.00%	30,000	Mar 31, 2023
VANGUARD GROUP INC	2.25%	-	1,478,153	34,990	2.42%	974,250,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	18,611	18,221	4672.05%	12,265,000	Mar 31, 2023
NORTHERN TRUST CORP	0.11%	-	71,241	12,643	21.58%	46,955,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	14,842	8,740	143.23%	10,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.04%	-	25,300	7,700	43.75%	17,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.04%	-	29,400	6,900	30.67%	19,000	Mar 31, 2023
BLACKROCK INC.	0.57%	-	375,247	2,718	0.73%	247,325,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.02%	-	11,100	2,600	30.59%	7,316,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.00%	-	2,125	1,300	157.58%	1,401,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.01%	-	5,309	5	0.09%	3,500,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	0.02%	-	10,129	-	-	6,676,000	Mar 31, 2023
STATE STREET CORP	0.17%	-	114,240	-	-	75,296,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.07%	-	43,732	-	-	28,824,000	Mar 31, 2023
COLUMN CAPITAL ADVISORS, LLC	0.00%	-	100	-	-	66,000	Mar 31, 2023
LARSON FINANCIAL GROUP LLC	0.00%	-	218	-	-	144,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.58%	-	378,667	-	-	249,579,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	27,225	-	-	17,933,000	Mar 31, 2023

As of Mar 31 2023, NRx Pharmaceuticals's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 52.90K stocks of NRXP, valued at $53.14M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	0.13%	-	88,300	-76,900	-46.55%	58,199,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.04%	0.00%	29,400	-75,300	-71.92%	19,378,000	Mar 31, 2023
AE WEALTH MANAGEMENT LLC	-	-	-	-29,515	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-27,800	-100.00%	-	Mar 31, 2023
EXCHANGE TRADED CONCEPTS, LLC	-	-	-	-26,924	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-26,501	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.03%	0.00%	21,326	-25,178	-54.14%	14,056,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.03%	-	18,200	-13,000	-41.67%	12,012,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	247	-12,309	-98.03%	163,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-10,453	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.05%	-	30,000	-5,809	-16.22%	19,770,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.02%	0.00%	11,141	-4,686	-29.61%	7,343,000	Mar 31, 2023
MORGAN STANLEY	0.07%	-	47,326	-3,012	-5.98%	31,193,000	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-1,000	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.01%	-	8,100	-400	-4.71%	5,339,000	Mar 31, 2023
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC	0.10%	0.00%	63,290	-	-	41,714,000	Mar 31, 2023
UNITED ASSET STRATEGIES, INC.	0.03%	0.00%	18,300	-	-	12,062,000	Mar 31, 2023
HBK SORCE ADVISORY LLC	0.09%	0.00%	58,460	-	-	58,000	Mar 31, 2023
CUTLER GROUP LLC / CA	0.00%	0.00%	3,220	-	-	2,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	27,225	-	-	17,933,000	Mar 31, 2023

As of Mar 31 2023, NRx Pharmaceuticals's biggest institutional seller is CITADEL ADVISORS LLC. The company sold -76.90K shares of NRXP, valued at $58.20M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.07%	0.00%	46,210	46,210	100.00%	30,000	Mar 31, 2023

NRx Pharmaceuticals's largest new institutional shareholder by number of shares is VIRTU FINANCIAL LLC, purchased 46.21K shares, valued at $30.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AE WEALTH MANAGEMENT LLC	-	-	-	-29,515	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-27,800	-100.00%	-	Mar 31, 2023
EXCHANGE TRADED CONCEPTS, LLC	-	-	-	-26,924	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-26,501	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-10,453	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-1,000	-100.00%	-	Mar 31, 2023

NRx Pharmaceuticals's largest sold out institutional shareholder by shares sold is AE WEALTH MANAGEMENT LLC, sold -29.52K shares, valued at -, as of undefined.

NRx Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
AdvisorShares Trust	0.15%	614,793	-27,839	-4.33%	Mar 28, 2024
BRIDGEWAY FUNDS INC	0.05%	122,700	-	-	Mar 28, 2024
RIVERNORTH OPPORTUNITIES FUND, INC.	0.03%	35,482	-	-	Jan 31, 2024
Virtus Event Opportunities Trust	0.02%	45,950	-	-	Mar 28, 2024
FIDELITY COMMONWEALTH TRUST	0.01%	41,024	-	-	Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS	0.01%	5,816	-	-	Mar 31, 2024
Vivaldi Opportunities Fund	0.00%	2,674	-	-	Mar 31, 2020
VANGUARD INDEX FUNDS	0.00%	1,431,772	-445,291	-23.72%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	393,484	6,137	1.58%	Feb 29, 2024
RiverNorth Funds	0.00%	35,274	-	-	Dec 31, 2023
TIMOTHY PLAN	0.00%	6,000	-	-	Mar 31, 2024
ETF Series Solutions	0.00%	26,924	-	-	Jan 31, 2024
SCHWAB CAPITAL TRUST	0.00%	43,732	-	-	Jan 31, 2024
Investment Managers Series Trust II	0.00%	13,056	-	-	Jan 31, 2024
Brinker Capital Destinations Trust	0.00%	50,724	-	-	Feb 29, 2024
Principal Exchange-Traded Funds	0.00%	6,801	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	8,273	-8,912	-51.86%	Mar 31, 2024
FIRST TRUST ALTERNATIVE OPPORTUNITIES FUND	0.00%	1,246	-	-	Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	1,074	-	-	Mar 31, 2024
PROSHARES TRUST	0.00%	5,689	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	4,373	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	6,649	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	77,884	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	1,258	-	-	Jan 31, 2024
AQR Funds	0.00%	200,000	-	-	Mar 31, 2024

NRx Pharmaceuticals's largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 614.79K shares, compromising 0.15% of its total assets.

NRx Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 21	5	-
31 Dec, 20	5	-
30 Sep, 20	5	-
30 Jun, 20	5	-16.67%
31 Mar, 20	6	-50.00%
31 Dec, 19	12	-14.29%
30 Sep, 19	14	-12.50%
30 Jun, 19	16	-15.79%
31 Mar, 19	19	-5.00%
31 Dec, 18	20	-
30 Sep, 18	20	5.26%
30 Jun, 18	19	-
31 Mar, 18	19	26.67%
31 Dec, 17	15	-

As of 31 Mar 21, 5 institutions are holding NRx Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 21	8,644	-38.23%
31 Dec, 20	13,994	-94.43%
30 Sep, 20	251,366	-40.63%
30 Jun, 20	423,407	-37.08%
31 Mar, 20	672,939	-73.35%
31 Dec, 19	2,524,788	-25.94%
30 Sep, 19	3,408,940	-19.47%
30 Jun, 19	4,233,158	-3.59%
31 Mar, 19	4,390,925	-2.12%
31 Dec, 18	4,486,190	-0.32%
30 Sep, 18	4,500,595	5.27%
30 Jun, 18	4,275,220	3.89%
31 Mar, 18	4,115,203	72.85%
31 Dec, 17	2,380,735	-

NRx Pharmaceuticals (NRXP) has 8.64K shares outstanding as of 31 Mar 21, down -38.23% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 21	0.03%	1513.97%
31 Dec, 20	0.04%	7.59%
30 Sep, 20	0.73%	48.05%
30 Jun, 20	1.24%	32.04%
31 Mar, 20	1.96%	3.62%
31 Dec, 19	7.37%	7.45%
30 Sep, 19	9.95%	6.52%
30 Jun, 19	12.35%	7.52%
31 Mar, 19	12.81%	7.48%
31 Dec, 18	13.09%	7.59%
30 Sep, 18	13.13%	8.44%
30 Jun, 18	12.47%	8.65%
31 Mar, 18	12.01%	24.88%
31 Dec, 17	6.95%	-

As of 31 Mar 21, NRx Pharmaceuticals is held by 0.03% institutional shareholders, representing a 1513.97% growth compared to 31 Dec 20.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 21	3	-25.00%
31 Dec, 20	4	100.00%
30 Sep, 20	2	-
30 Jun, 20	-	-100.00%
31 Mar, 20	3	50.00%
31 Dec, 19	2	-
30 Sep, 19	2	-75.00%
30 Jun, 19	8	14.29%
31 Mar, 19	7	75.00%
31 Dec, 18	4	-42.86%
30 Sep, 18	7	-22.22%
30 Jun, 18	9	-35.71%
31 Mar, 18	14	-6.67%
31 Dec, 17	15	-

3 institutional shareholders have increased their position in NRXP stock as of 31 Mar 21 compared to 4 in the previous quarter (a -25.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 21	2	100.00%
31 Dec, 20	1	-50.00%
30 Sep, 20	2	-33.33%
30 Jun, 20	3	-
31 Mar, 20	3	50.00%
31 Dec, 19	2	-60.00%
30 Sep, 19	5	150.00%
30 Jun, 19	2	-50.00%
31 Mar, 19	4	-20.00%
31 Dec, 18	5	66.67%
30 Sep, 18	3	50.00%
30 Jun, 18	2	-
31 Mar, 18	-	-
31 Dec, 17	-	-

2 institutional shareholders have reduced their position in NRXP stock as of 31 Mar 21 compared to 1 in the previous quarter (a 100.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 21	5	-	8,644	-38.23%	0.03%	1513.97%	3	-25.00%	2	100.00%
31 Dec, 20	5	-	13,994	-94.43%	0.04%	7.59%	4	100.00%	1	-50.00%
30 Sep, 20	5	-	251,366	-40.63%	0.73%	48.05%	2	-	2	-33.33%
30 Jun, 20	5	-16.67%	423,407	-37.08%	1.24%	32.04%	-	-100.00%	3	-
31 Mar, 20	6	-50.00%	672,939	-73.35%	1.96%	3.62%	3	50.00%	3	50.00%
31 Dec, 19	12	-14.29%	2,524,788	-25.94%	7.37%	7.45%	2	-	2	-60.00%
30 Sep, 19	14	-12.50%	3,408,940	-19.47%	9.95%	6.52%	2	-75.00%	5	150.00%
30 Jun, 19	16	-15.79%	4,233,158	-3.59%	12.35%	7.52%	8	14.29%	2	-50.00%
31 Mar, 19	19	-5.00%	4,390,925	-2.12%	12.81%	7.48%	7	75.00%	4	-20.00%
31 Dec, 18	20	-	4,486,190	-0.32%	13.09%	7.59%	4	-42.86%	5	66.67%
30 Sep, 18	20	5.26%	4,500,595	5.27%	13.13%	8.44%	7	-22.22%	3	50.00%
30 Jun, 18	19	-	4,275,220	3.89%	12.47%	8.65%	9	-35.71%	2	-
31 Mar, 18	19	26.67%	4,115,203	72.85%	12.01%	24.88%	14	-6.67%	-	-
31 Dec, 17	15	-	2,380,735	-	6.95%	-	15	-	-	-

NRx Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 11, 2023	Gorovitz Aaron	director	-	P-Purchase	Buy	35,000	$0.32	$11.20K	105,000
Sep 11, 2023	Hurvitz Chaim	director	-	P-Purchase	Buy	70,000	$0.29	$20.13K	570,000
Aug 24, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	100,000	$0.33	$33.00K	446,332
Aug 23, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	200,000	$0.32	$64.40K	346,332
Dec 19, 2022	Willard Stephen H	director	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	50,000	$1.17	$58.50K	50,000
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	30,000	$1.10	$33.00K	46,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	600	$1.10	$660.00	9,316
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	8,716	$1.12	$9.76K	8,716
Dec 09, 2022	Javitt Jonathan C	director	-	S-Sale	Sell	400,000	$1.00	$400.00K	12,899,997
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	13,730	$1.50	$20.65K	9,643,234
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	8,441	$1.50	$12.70K	9,634,793
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.24	$3.10K	40,209
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.25	$3.13K	37,709
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	1,750	$1.25	$2.19K	1,750
Nov 28, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,377

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 11, 2023	Gorovitz Aaron	director	-	P-Purchase	Buy	35,000	$0.32	$11.20K	105,000
Sep 11, 2023	Hurvitz Chaim	director	-	P-Purchase	Buy	70,000	$0.29	$20.13K	570,000
Aug 24, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	100,000	$0.33	$33.00K	446,332
Aug 23, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	200,000	$0.32	$64.40K	346,332
Dec 19, 2022	Willard Stephen H	director	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	50,000	$1.17	$58.50K	50,000
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	30,000	$1.10	$33.00K	46,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	600	$1.10	$660.00	9,316
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	8,716	$1.12	$9.76K	8,716
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.24	$3.10K	40,209
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.25	$3.13K	37,709
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	1,750	$1.25	$2.19K	1,750
Nov 28, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,377

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 26, 2024	McBride Dennis	director	-		Sell	6,320	$15.30	$96.70K	-
Dec 09, 2022	Javitt Jonathan C	director	-	S-Sale	Sell	400,000	$1.00	$400.00K	12,899,997
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	13,730	$1.50	$20.65K	9,643,234
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	8,441	$1.50	$12.70K	9,634,793

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 26, 2024	McBride Dennis	director	-		Sell	6,320	$15.30	$96.70K	-
Jan 16, 2024	Rehnquist Janet	director			Buy	-	-	-	-
Sep 19, 2023	Narido Richard Clavano	officer	-		Buy	-	-	-	-
Sep 11, 2023	Gorovitz Aaron	director	-	P-Purchase	Buy	35,000	$0.32	$11.20K	105,000
Sep 11, 2023	Hurvitz Chaim	director	-	P-Purchase	Buy	70,000	$0.29	$20.13K	570,000
Aug 24, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	100,000	$0.33	$33.00K	446,332
Aug 23, 2023	Javitt Jonathan C	director, 10 percent owner, officer	Chief Scientist	P-Purchase	Buy	200,000	$0.32	$64.40K	346,332
Feb 14, 2023	Javitt Jonathan C		-		Buy	-	-	-	-
Dec 19, 2022	Willard Stephen H	director	CHIEF EXECUTIVE OFFICER	P-Purchase	Buy	50,000	$1.17	$58.50K	50,000
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	30,000	$1.10	$33.00K	46,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,337
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	600	$1.10	$660.00	9,316
Dec 19, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	8,716	$1.12	$9.76K	8,716
Dec 09, 2022	Javitt Jonathan C	director	-	S-Sale	Sell	400,000	$1.00	$400.00K	12,899,997
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	13,730	$1.50	$20.65K	9,643,234
Dec 01, 2022	Javitt Daniel C.	director	-	S-Sale	Sell	8,441	$1.50	$12.70K	9,634,793
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.24	$3.10K	40,209
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	2,500	$1.25	$3.13K	37,709
Nov 29, 2022	Flynn Patrick John	director	-	P-Purchase	Buy	1,750	$1.25	$2.19K	1,750
Nov 28, 2022	VAN VOORHEES SETH	director	CHIEF FINANCIAL OFFICER	P-Purchase	Buy	7,021	$1.11	$7.79K	16,377

The last insider sell of NRx Pharmaceuticals's stock was made by McBride Dennis on Jun 26 2024, selling 6,320 shares at $15.30 per share (valued at $96.70K). The last insider buy of NRXP was made by Gorovitz Aaron on Sep 11 2023, buying 35,000 shares at $0.32 per share (worth $11.20K).

NRx Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	1	-
Q1 2024	-	1	-
Q4 2023	-	-	-
Q3 2023	4	-	-
Q4 2022	21	6	350.00%
Q3 2022	-	3	-
Q2 2022	2	2	100.00%
Q1 2022	1	-	-
Q3 2021	10	9	111.11%
Q2 2021	26	5	520.00%
Q1 2020	-	1	-
Q4 2018	-	1	-
Q4 2017	3	2	150.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by NRx Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	4	-	-
Q4 2022	17	6	283.33%
Q3 2022	-	1	-
Q2 2022	2	1	200.00%
Q1 2022	-	-	-
Q3 2021	-	2	-
Q2 2021	1	-	-
Q1 2020	-	1	-
Q4 2018	-	1	-
Q4 2017	3	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of NRx Pharmaceuticals's stocks.

NRx Pharmaceuticals Peer Ownership

Ticker	Company
SNTI	Senti Biosciences, Inc.
BLCM	Bellicum Pharmaceuticals, Inc.
NTRB	Nutriband Inc.
LEXX	Lexaria Bioscience Corp.
LGVN	Longeveron Inc.
ADTX	Aditxt, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
CING	Cingulate Inc.
VRAX	Virax Biolabs Group Limited
RNXT	RenovoRx, Inc.

NRXP Ownership FAQ

Who Owns NRx Pharmaceuticals?

NRx Pharmaceuticals is owned by institutional shareholders (0.03%), insiders (26.55%), and public (73.42%). The largest institutional shareholder of NRx Pharmaceuticals is VANGUARD GROUP INC (2.25% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.15% of total shares).

Who are the major institutional shareholders of NRx Pharmaceuticals?

NRx Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BLACKROCK INC., BRIDGEWAY CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. The top five shareholders own together 3.92% of the company's share outstanding.

How many NRx Pharmaceuticals shareholders are there?

As of Mar 2021, there are 5 institutional shareholders of NRx Pharmaceuticals.

What percentage of NRx Pharmaceuticals is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 1.48M shares of NRx Pharmaceuticals, representing 2.25% of the company's total shares outstanding, valued at $974.25M (as of Mar 2023).

What percentage of NRx Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Mar 2023, GEODE CAPITAL MANAGEMENT, LLC holds 378.67K shares of NRx Pharmaceuticals (NRXP), compromising 0.58% of the company, valued at $249.58M.

What percentage of NRx Pharmaceuticals is owned by BLACKROCK INC?

BLACKROCK INC is the third largest holder of NRx Pharmaceuticals. The company owns 375.25K of the company's shares outstanding (worth $247.32M).